Patiromer Acetate Induced Hypercalcemia: An Unreported Adverse Effect
Hyperkalemia, a potential life threating condition, is a commonly encountered problem in chronic kidney disease (CKD) patients. Patiromer acetate, a nonabsorbable cation exchange polymer, is a gastrointestinal agent for chronic therapy in patients with persistent hyperkalemia. Patiromer is generally...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Case Reports in Nephrology |
| Online Access: | http://dx.doi.org/10.1155/2019/3507407 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832566790598688768 |
|---|---|
| author | Shreeyukta Bhattarai Stephen Pupillo Gulshan Man Singh Dangol Erdal Sarac |
| author_facet | Shreeyukta Bhattarai Stephen Pupillo Gulshan Man Singh Dangol Erdal Sarac |
| author_sort | Shreeyukta Bhattarai |
| collection | DOAJ |
| description | Hyperkalemia, a potential life threating condition, is a commonly encountered problem in chronic kidney disease (CKD) patients. Patiromer acetate, a nonabsorbable cation exchange polymer, is a gastrointestinal agent for chronic therapy in patients with persistent hyperkalemia. Patiromer is generally well tolerated in patients; common side effects are gastrointestinal, such as diarrhea, constipation, flatulence, and vomiting. Hypercalcemia, although a theoretical possibility, has not been reported in any major clinical trials. We present a case of hypercalcemia associated with patiromer acetate used for treatment of hyperkalemia in a stage IV CKD patient. Clinicians should be aware of the possibility of hypercalcemia while taking patiromer. |
| format | Article |
| id | doaj-art-e81c3b234aed4af4915cf8db2e497126 |
| institution | Kabale University |
| issn | 2090-6641 2090-665X |
| language | English |
| publishDate | 2019-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Nephrology |
| spelling | doaj-art-e81c3b234aed4af4915cf8db2e4971262025-02-03T01:03:17ZengWileyCase Reports in Nephrology2090-66412090-665X2019-01-01201910.1155/2019/35074073507407Patiromer Acetate Induced Hypercalcemia: An Unreported Adverse EffectShreeyukta Bhattarai0Stephen Pupillo1Gulshan Man Singh Dangol2Erdal Sarac3Northeast Ohio Medical University, Department of Medicine, Rootstown, Ohio, USANortheast Ohio Medical University, Department of Medicine, Rootstown, Ohio, USANortheast Ohio Medical University, Department of Medicine, Rootstown, Ohio, USANortheast Ohio Medical University, Department of Medicine, Rootstown, Ohio, USAHyperkalemia, a potential life threating condition, is a commonly encountered problem in chronic kidney disease (CKD) patients. Patiromer acetate, a nonabsorbable cation exchange polymer, is a gastrointestinal agent for chronic therapy in patients with persistent hyperkalemia. Patiromer is generally well tolerated in patients; common side effects are gastrointestinal, such as diarrhea, constipation, flatulence, and vomiting. Hypercalcemia, although a theoretical possibility, has not been reported in any major clinical trials. We present a case of hypercalcemia associated with patiromer acetate used for treatment of hyperkalemia in a stage IV CKD patient. Clinicians should be aware of the possibility of hypercalcemia while taking patiromer.http://dx.doi.org/10.1155/2019/3507407 |
| spellingShingle | Shreeyukta Bhattarai Stephen Pupillo Gulshan Man Singh Dangol Erdal Sarac Patiromer Acetate Induced Hypercalcemia: An Unreported Adverse Effect Case Reports in Nephrology |
| title | Patiromer Acetate Induced Hypercalcemia: An Unreported Adverse Effect |
| title_full | Patiromer Acetate Induced Hypercalcemia: An Unreported Adverse Effect |
| title_fullStr | Patiromer Acetate Induced Hypercalcemia: An Unreported Adverse Effect |
| title_full_unstemmed | Patiromer Acetate Induced Hypercalcemia: An Unreported Adverse Effect |
| title_short | Patiromer Acetate Induced Hypercalcemia: An Unreported Adverse Effect |
| title_sort | patiromer acetate induced hypercalcemia an unreported adverse effect |
| url | http://dx.doi.org/10.1155/2019/3507407 |
| work_keys_str_mv | AT shreeyuktabhattarai patiromeracetateinducedhypercalcemiaanunreportedadverseeffect AT stephenpupillo patiromeracetateinducedhypercalcemiaanunreportedadverseeffect AT gulshanmansinghdangol patiromeracetateinducedhypercalcemiaanunreportedadverseeffect AT erdalsarac patiromeracetateinducedhypercalcemiaanunreportedadverseeffect |